An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma
- PMID: 11431364
An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma
Abstract
The step of intravasation (lymphovascular invasion), a rate-limiting step in metastasis, is greatly exaggerated in inflammatory breast carcinoma (IBC). Because nearly all human breast carcinoma cell lines grow as solitary nodules in nude/severe combined immunodeficient mice without manifesting lymphovascular invasion, this step has been difficult to study. We captured the essence of the IBC phenotype by establishing a unique human transplantable IBC xenograft, MARY-X, which manifests florid lymphovascular emboli in severe combined immunodeficient/nude mice. Comparing MARY-X with common non-IBC cell lines/xenografts, we discovered an overexpressed and overfunctioning E-cadherin/alpha,beta-catenin axis. In MARY-X, the E-cadherin and catenins were part of a structurally and functionally intact adhesion axis involving the actin cytoskeleton. In vitro, MARY-X grew as round compact spheroids with a cell density 5-10-fold higher than that of other lines. The spheroids of MARY-X completely disadhered when placed in media containing absent Ca(2+) or anti-E-cadherin antibodies or when retrovirally transfected with a dominant-negative E-cadherin mutant (H-2K(d)-E-cad). Anti-E-cadherin antibodies injected i.v. immunolocalized to the pulmonary lymphovascular emboli of MARY-X and caused their dissolution. H-2K(d)-E-cad-transfected MARY-X spheroids were only weakly tumorigenic and did not form lymphovascular emboli. A total of 90% of human IBCs showed increased membrane E-cadherin/alpha,beta-catenin immunoreactivity. These findings indicate that it is the gain and not the loss of the E-cadherin axis that contributes to the IBC phenotype.
Similar articles
-
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.Oncogene. 2002 May 16;21(22):3631-43. doi: 10.1038/sj.onc.1205389. Oncogene. 2002. PMID: 12032865
-
Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.Am J Pathol. 2002 Aug;161(2):619-28. doi: 10.1016/S0002-9440(10)64217-4. Am J Pathol. 2002. PMID: 12163386 Free PMC article.
-
E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.Anticancer Res. 2010 Oct;30(10):3903-10. Anticancer Res. 2010. PMID: 21036701
-
Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.Princess Takamatsu Symp. 1994;24:63-80. Princess Takamatsu Symp. 1994. PMID: 8983064 Review.
-
Alterations of the cadherin-catenin cell adhesion system in cancers.Princess Takamatsu Symp. 1994;24:51-62. Princess Takamatsu Symp. 1994. PMID: 8983063 Review.
Cited by
-
Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.Virchows Arch. 2013 Jun;462(6):653-63. doi: 10.1007/s00428-013-1427-z. Epub 2013 May 17. Virchows Arch. 2013. PMID: 23681114
-
Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis.Cancer Sci. 2012 Jul;103(7):1342-7. doi: 10.1111/j.1349-7006.2012.02275.x. Epub 2012 Apr 23. Cancer Sci. 2012. PMID: 22429811 Free PMC article.
-
Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis.PLoS One. 2009 Aug 13;4(8):e6636. doi: 10.1371/journal.pone.0006636. PLoS One. 2009. PMID: 19675678 Free PMC article.
-
ERalpha suppresses slug expression directly by transcriptional repression.Biochem J. 2008 Dec 1;416(2):179-87. doi: 10.1042/BJ20080328. Biochem J. 2008. PMID: 18588516 Free PMC article.
-
Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.Nutr Cancer. 2011;63(7):1085-94. doi: 10.1080/01635581.2011.601845. Epub 2011 Sep 2. Nutr Cancer. 2011. PMID: 21888505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous